How Does mTOR Pathway Dysregulation Lead to Cancer?
Dysregulation can occur through mutations in genes encoding pathway components or upstream regulators. For example, loss-of-function mutations in TSC1/TSC2 or PTEN can lead to unchecked mTOR activity. This results in enhanced protein synthesis, reduced autophagy, and increased cell survival, creating a favorable environment for tumor development.
